PhRMA
FEBRUARY 23, 2023
State legislative sessions across the country are in full swing, and many state officials have made lowering the cost of medicine for patients a top priority. If policymakers are serious about addressing high out-of-pocket costs for patients, they should start by taking steps to finally hold pharmacy benefit managers (PBMs) accountable.
Drug Topics
FEBRUARY 20, 2023
Not only were people with newly diagnosed type 2 diabetes less likely to develop dementia if they took pioglitazone, but the benefit was stronger among patients with a history of ischemic heart disease or stroke.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
FEBRUARY 21, 2023
A bedrock of the U.S. mental health system — a nine-item questionnaire used to spot depression — began not with a doctor, but with a marketing man. Howard Kroplick, now 73 years old and living on Long Island, is obsessed with antique racing cars and, in his storied career in the pharmaceutical industry, crucially urged Pfizer to avoid the word “impotence” when promoting Viagra.
European Pharmaceutical Review
FEBRUARY 21, 2023
The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabin
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PhRMA
FEBRUARY 21, 2023
There have been some alarming stories uncovered by the media on ways nonprofit hospitals — many of which participate in the 340B drug pricing program — are taking advantage of the system and their tax-exempt status to boost their bottom lines, at the expense of patients.
Drug Topics
FEBRUARY 22, 2023
The World Health Organization (WHO) and the CDC recommend different doses when it comes to vaccine protection against the human papillomavirus (HPV).
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
European Pharmaceutical Review
FEBRUARY 24, 2023
University Hospital Erlangen in Germany is the first in the world to use chimeric antigen receptor (CAR) T-cells to successfully treat a patient suffering from a severe case of muscle inflammation (myositis). The researchers noted that risk of developing a very severe form of the autoimmune inflammatory disease is high. The patient who received the CAR T treatment was diagnosed with anti-synthetase syndrome.
PhRMA
FEBRUARY 23, 2023
PhRMA responded to the U.S. Patent and Trademark Office’s (USPTO) request for comments regarding USPTO initiatives to ensure the robustness and reliability of patent rights.
Drug Topics
FEBRUARY 24, 2023
Pharmacists generally agree that domestic production of the commonly used antibiotic could prevent more shortages from happening in the future
STAT
FEBRUARY 24, 2023
A classic warning in public health goes like this: “A society that spends so much on health care that it cannot or will not spend adequately on other health enhancing activities may actually be reducing the health of its population.” No nation is as guilty of this practice as the United States, with its extremely high health expenditures alongside abysmal population-level health outcomes.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
FEBRUARY 23, 2023
GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme. This collaboration is expected to help expedite the clinical manufacturing of RVM-V001 and future mRNA-based vaccines that target infectious diseases such as Clostriodioides difficile infection (CDI) and R
PhRMA
FEBRUARY 22, 2023
People around the country say they are paying too much for their prescription medicines. State policymakers could help address this problem now. Doing so starts with stopping pharmacy benefit managers (PBMs) from taking advantage of the health system and patients.
Drug Topics
FEBRUARY 21, 2023
With nearly 250,000 kindergarten age children not receiving their recommended vaccines, pediatric health care providers search for solutions.
Fierce Healthcare
FEBRUARY 24, 2023
Major coalition of health groups aims to combat health misinformation rking Fri, 02/24/2023 - 11:17
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
FEBRUARY 21, 2023
Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL MONITORING Endotoxin trends: sustainability, automation and beyond Miriam Guest, AstraZeneca UK REGULATORY INSIGHT UPC opt-out – a strateg
STAT
FEBRUARY 24, 2023
As a health policy wonk and health economist who has worked in pharmaceutical companies in the United States, Latin America, and Europe, I’ve seen vast volumes of data generated, gathered, aggregated, analyzed, shared, and resold by health care companies and organizations. In my studies with the world’s top medical statistics experts at the University of Oxford’s Centre for Evidence Based Medicine, I’ve also seen how flawed many datasets are, missing critical data pie
Drug Topics
FEBRUARY 22, 2023
Previous surveys suggested care disparities. Investigators compared these outcomes because of a lack of research in this space.
Pharmaceutical Technology
FEBRUARY 22, 2023
Amgen could be the winner of a high-stakes patent spat with Sanofi as tensions run high weeks before the March 27 US Supreme Court hearing. While some courts were previously on Sanofi’s side, it is possible that Amgen’s case could win this time, some legal experts say. However, Sanofi’s side also has significant support, highlighting the dispute’s contentious nature.
Drug Store News
FEBRUARY 21, 2023
Consumers are obsessed with their hair, whether it be washing, styling, removing or growing. Here are what experts predict will keep sales bouncy in the new year.
STAT
FEBRUARY 22, 2023
Stroke risk prediction tools are meant to guide how doctors approach a potentially deadly condition, using factors like heart disease and high blood pressure to get a handle on which patients might benefit from a particular treatment. For years, doctors have used several different algorithms to try to capture the true risk of stroke, including newer models that use machine learning.
Drug Topics
FEBRUARY 21, 2023
Researchers estimate the protection from COVID-19 reinfection based on the variant and time since a patient's previous infection.
European Pharmaceutical Review
FEBRUARY 24, 2023
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of ruxolitinib cream (Opzelura ) for non-segmental vitiligo with facial involvement in people over 12 years old. “With no centrally approved treatment option currently available in the EU, this positive opinion marks a significant milestone for the vitiligo community,” explained Dr Steven Stein, Chief Medical Officer, Chief Medical Officer, Incyte.
Drug Store News
FEBRUARY 23, 2023
New from the brand is the Hydrating Body Wash and Intense Anti-Dry Body Lotion, which will be available in two scents inspired by the brand’s fine fragrance collection.
STAT
FEBRUARY 21, 2023
This year could shape up to be a historic one for tobacco control — or one in which Big Tobacco accelerates its steady transformation into Big Nicotine. We are hoping for the former, but aren’t betting against the latter. For the last few years, the tobacco industry has publicly endorsed harm reduction. This public health strategy includes efforts designed to reduce, though not eliminate, risks for people who engage in harmful behaviors.
Drug Topics
FEBRUARY 22, 2023
More traditional health care coverage will begin when the U.S. public health emergency response to COVID-19 ends on May 11.
Fierce Healthcare
FEBRUARY 23, 2023
Google, Microsoft execs share how racial bias can hinder expansion of health AI rking Thu, 02/23/2023 - 12:36
Drug Store News
FEBRUARY 24, 2023
The study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments.
STAT
FEBRUARY 19, 2023
Watching news reports of the heroic relief efforts underway in Turkey and Syria following the devastating earthquake there, I can imagine the terrible weight of emotional trauma that so many people are experiencing right now because I’ve experienced it myself. A dozen years ago, as a young doctor with a background in emergency medicine, I felt prepared to handle disaster response situations.
Drug Topics
FEBRUARY 21, 2023
The vaccine was 73.2% effective in children aged 6 months to 4 years when administered during the Omicron-dominant phase.
Fierce Healthcare
FEBRUARY 22, 2023
Costly discharge delays highlight need for more downstream care options, New York group's analysis shows dmuoio Wed, 02/22/2023 - 12:48
Drug Store News
FEBRUARY 22, 2023
One Medical offers in-office and 24/7 virtual care services, on-site labs and programs for preventive care, chronic care management, common illnesses and mental health concerns.
STAT
FEBRUARY 23, 2023
Ovarian cancer has long been one of the deadliest cancers to strike women. No tests are available to detect it early, so most patients are diagnosed in later stages, when the cancer is more likely to have spread. Fewer than half of women survive 5 years past their diagnosis, and 80 percent have no known risk factors. Now, a growing chorus of physicians is recommending a procedure that can significantly reduce the chances of developing ovarian cancer.
Drug Topics
FEBRUARY 24, 2023
Leading health organizations are urging those with diabetes and other chronic conditions to get the influenza vaccine.
Fierce Healthcare
FEBRUARY 22, 2023
Hospital lobby urges FTC to withdraw or add healthcare exceptions to sweeping noncompete ban dmuoio Wed, 02/22/2023 - 15:55
Expert insights. Personalized for you.
277 
Let's personalize your content